Veru Says USPTO Issued Notice Of Allowance For Patent Covering Enobosarm Combined With Weight Loss Drugs, With Protection Until At Least October 2044
Share
Why It Matters
Veru got approval from the government to protect their idea for using two medicines together to help with weight loss until 2044. When a company gets a long patent, it means they can be the only ones selling that idea for a long time, which could be valuable.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.